Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

44 resultsUpdated October 21, 2026
1

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma

PLOS ONE 11(12) (2016)

Hong-Wei Sun; Xing-Juan Yu; Wen-Chao Wu; Jing Chen; Ming Shi; Limin Zheng; Jing Xu

3

Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma

Oncotarget 8(8) (2017)

Mingyang Ma; Shuyao Hua; Gang Li; Sumei Wang; Xue Cheng; Songqing He; Ping Wu; Xiaoping Chen

4

Activity and Expression Pattern of NF-κB/P65 in Peripheral Blood from Hepatocellular Carcinoma Patients - Link to Hypoxia Inducible Factor -1α

Asian Pacific Journal of Cancer Prevention 15(16) (2014)

Hanaa Hibishy Gaballah; Soha Said Zakaria; Saber Abdelrahman Ismail

5

Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study

PLOS ONE 11(7) (2016)

Liling Huang; Cunxu Liu; Yan Deng; Yanqiong Liu; Jiangyang Zhao; Xiuli Huang; Wenjun Tang; Yifan Sun; Xue Qin; Shan Li

6

Modulatory Effect of 4-(methylthio)butyl Isothiocyanate Isolated From Eruca Sativa Thell. on DMBA Induced Overexpression of Hypoxia and Glycolytic Pathway in Sprague-Dawley Female Rats

Frontiers in Pharmacology 12 (2021)

Davinder Singh; Sharad Thakur; Drishtant Singh; Harpal Singh Buttar; Balbir Singh; Saroj Arora

7

Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth

World Journal of Gastroenterology 27(23) (2021)

Meng-Na Wu; Wen-Jie Zheng; Wen-Xin Ye; Li Wang; Ying Chen; Jie Yang; Deng-Fu Yao; Min Yao

9

Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma

Medical Science Monitor 27 (2021)

Lan-Lan Wang; Chen Liao; Xiao-Qiang Li; Rong Dai; Qing-Wei Ren; Hai-Long Shi; Xiao-Ping Wang; Xue-Song Feng; Xu Chao

10

Hypoxia-inducible factor-1α as prognostic marker

Expert Opinion on Medical Diagnostics 7(1) (2012)

Amin Ben Lassoued; Nathalie Beaufils; Jean-Philippe Dales; Jean Gabert

11

Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)

Current Cancer Drug Targets 15(5) (2015)

Angela Lamarca; Marta Mendiola; Elsa Bernal; Victoria Heredia; Esther Díaz; María Miguel; Laura Pastrian; Emilio Burgos; Jaime Feliu; Jorge Barriuso

13

Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells

British Journal of Cancer 109(1) (2013)

S Carbajo-Pescador; R Ordoñez; M Benet; R Jover; A García-Palomo; J L Mauriz; J González-Gallego

14

<p>Upregulation of hypoxia-inducible factor 1α mRNA expression was associated with poor prognosis in patients with hepatocellular carcinoma</p>

OncoTargets and Therapy Volume 12 (2019)

Wei Cheng; Ziwei Cheng; Zongguo Yang; Dongwei Xing; Minguang Zhang

15
16

Role of mitochondria in liver metabolic health and diseases

Cell Calcium 94 (2021)

Béatrice Morio; Baptiste Panthu; Arthur Bassot; Jennifer Rieusset

17

Proangiogenic factors in the development of HCC in alcoholic cirrhosis

Clinics and Research in Hepatology and Gastroenterology 39 (2015)

Mariana V. Machado; Helena Cortez-Pinto

18

Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: A systematic review with meta-analysis

Clinics and Research in Hepatology and Gastroenterology 38(5) (2014)

Shiyi Cao; Shengli Yang; Chao Wu; Yunxia Wang; Jianxin Jiang; Zuxun Lu

19

The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma

Expert Review of Gastroenterology & Hepatology 8(4) (2014)

Dalvinder S Mandair; Roberta E Rossi; Marinos Pericleous; Tara Whyand; Martyn Caplin

20

Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods

International Journal of Molecular Sciences 23(6) (2022)

Milos Mihajlovic; Mathieu Vinken

21

Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma

Tumor Biology 37(4) (2015)

Liuhong Pan; Min Yao; Wenjie Zheng; Juanjuan Gu; Xuli Yang; Liwei Qiu; Yin Cai; Wei Wu; Dengfu Yao

22

Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling

Scientific Reports 7(1) (2017)

Peng Liu; Samuel J. Atkinson; Sophia E. Akbareian; Zhigang Zhou; Andrea Munsterberg; Stephen D. Robinson; Yongping Bao

23

Roles of Copper in Hepatocarcinogenesis via the Activation of Hypoxia-Inducible Factor-1α

Biological Trace Element Research 174(1) (2016)

Takashi Himoto; Koji Fujita; Takako Nomura; Joji Tani; Hisaaki Miyoshi; Asahiro Morishita; Hirohito Yoneyama; Satoru Kubota; Reiji Haba; Yasuyuki Suzuki; Tsutomu Masaki

24

Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma

Mini-Reviews in Medicinal Chemistry 13(9) (2013)

Z. Dong; M. Yao; L. Wang; W. Wu; X. Gu; D. Yao

25

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma

PLOS ONE 10(3) (2015)

Wei-Ju Huang; Yung-Ming Jeng; Hong-Shiee Lai; Iok-U Fong; Fang-Yu Bonnie Sheu; Po-Lin Lai; Ray-Hwang Yuan

26

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis

Hepatitis Monthly 15(12) (2015)

Wenli Sai; Li Wang; Wenjie Zheng; Junling Yang; Liuhong Pan; Yin Cai; Liwei Qiu; Haijian Zhang; Wei Wu; Dengfu Yao

27

<p>Transcatheter arterial embolization combined with hypoxia-replicative oncolytic adenovirus perfusion enhances the therapeutic effect of hepatic carcinoma</p>

Cancer Management and Research Volume 11 (2019)

Hongsen Zhang; Fu Xiong; Kun Qian; Yiming Liu; Bin Liang; Bin Xiong; Fan Yang; Chuansheng Zheng

28

The Correlation of Expression Levels of HIF-1  and HIF-2  in Hepatocellular Carcinoma with Capsular Invasion, Portal Vein Tumor Thrombi and Patients' Clinical Outcome

Japanese Journal of Clinical Oncology 44(2) (2013)

S.-L. Yang; L.-P. Liu; J.-X. Jiang; Z.-F. Xiong; Q.-J. He; C. Wu

29

Early monitoring values of oncogenic signalling molecules for hepatocellular carcinoma

World Journal of Gastrointestinal Oncology 16(6) (2024)

Min Yao; Rong-Fei Fang; Qun Xie; Min Xu; Wen-Li Sai; Deng-Fu Yao

30

Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy

Tumor Biology 35(6) (2014)

Min Yao; Li Wang; Zhizhen Dong; Qi Qian; Yun Shi; Dandan Yu; Shiye Wang; Wenjie Zheng; Dengfu Yao

31

Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis

Oncology Letters 7(1) (2013)

ZHIZHEN DONG; MIN YAO; HAIJIAN ZHANG; LI WANG; HUA HUANG; MEIJUAN YAN; WEI WU; DENGFU YAO

32

Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells

Tumor Biology 34(6) (2013)

Zhizhen Dong; Min Yao; Li Wang; Xiaodi Yan; Xing Gu; Yun Shi; Ninghua Yao; Liwei Qiu; Wei Wu; Dengfu Yao

34

Prospects and Challenges for T Cell-Based Therapies of HCC

Cells 10(7) (2021)

Norman Woller; Sophie Anna Engelskircher; Thomas Wirth; Heiner Wedemeyer

35

Liver Zonation in Health and Disease: Hypoxia and Hypoxia-Inducible Transcription Factors as Concert Masters

International Journal of Molecular Sciences 20(9) (2019)

Thomas Kietzmann

36

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma

Frontiers in Oncology 13 (2023)

Shuqi Xie; Mengchao Wang; Chuanxiu Zeng; Yan Ou; Lu Zhao; Dong Wang; Liwei Chen; Fanming Kong; Dan Yi

37

Hypoxia-inducible factors as molecular targets for liver diseases

Journal of Molecular Medicine 94(6) (2016)

Cynthia Ju; Sean P. Colgan; Holger K. Eltzschig

38

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma

BioMed Research International 2014 (2014)

Dongjun Luo; Zhongxia Wang; Junyi Wu; Chunping Jiang; Junhua Wu

39

Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination

Journal of Gastrointestinal Cancer 52(1) (2020)

Shereen El Shorbagy; Fouad abuTaleb; Hany A. Labib; Huda Ebian; Ola A. Harb; Mona Saeed Mohammed; Hanaa A. Rashied; Khaled A. Elbana; Rasha Haggag

40

Conjugated Linoleic Acids Inhibit Hypoxia Inducible Factor-1^|^alpha; Stabilization under Hypoxic Condition in Human Hepatocellular Carcinoma Cells

Journal of Oleo Science 61(9) (2012)

Masao Yamasaki; Taku Nagatomo; Tetsuya Matsuyama; Yuri Ikeho; Emiko Kato; Kei Nishiyama; Yoichi Sakakibara; Masahito Suiko; Kazuo Nishiyama

41

Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibitingNF-κBgene transcription

World Journal of Hepatology 8(23) (2016)

Wei Wu; Jun-Ling Yang; Yi-Lang Wang; Han Wang; Min Yao; Li Wang; Juan-Juan Gu; Yin Cai; Yun Shi; Deng-Fu Yao

42

Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma

Oncotarget 7(19) (2016)

Julia Herzog; Sandra M. Ehrlich; Lisa Pfitzer; Johanna Liebl; Thomas Fröhlich; Georg J. Arnold; Wolfgang Mikulits; Christine Haider; Angelika M. Vollmar; Stefan Zahler

43

Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: The role of hypoxia inducible factor 1 pathway

Toxicology Letters 222(2) (2013)

Guangwen Shu; Xue Mi; Jian Cai; Xinlin Zhang; Wu Yin; Xinzhou Yang; You Li; Lvyi Chen; Xukun Deng

44

Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis

European Journal of Gastroenterology & Hepatology 26(4) (2014)

Mariana V. Machado; André Janeiro; Gabriel Miltenberger-Miltenyi; Helena Cortez-Pinto